Trials / Completed
CompletedNCT02261337
Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?
Do Gait Speed and Markers of Sarcopenia Predict Prognosis in Patients With Chronic Respiratory Disease?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 565 (actual)
- Sponsor
- Royal Brompton & Harefield NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess usual walking speed (4-metre gait speed) and markers of sarcopenia predict mortality in patients with chronic respiratory disease.
Conditions
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2018-04-01
- Completion
- 2022-04-01
- First posted
- 2014-10-10
- Last updated
- 2022-11-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02261337. Inclusion in this directory is not an endorsement.